These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22991101)

  • 1. Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Amin N; Reddy K; Westerly D; Raben D; DeWitt P; Chen C
    Laryngoscope; 2012 Dec; 122(12):2736-42. PubMed ID: 22991101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
    Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
    Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
    Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
    Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
    Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
    Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can dysphagia aspiration related structures (DARS) be spared in patients with oropharyngeal cancers? Dosimetric evaluation in a prospective study of DARS optimized intensity modulated radiation therapy.
    Calcuttawala A; Shinghal A; Budrukkar AN; Swain M; Murthy V; Laskar SG; Gupta T; Upereti R; Kale S; Agarwal JP
    J Cancer Res Ther; 2024 Jul; 20(5):1499-1506. PubMed ID: 39412914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
    Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
    Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
    Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
    Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
    Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of PEG dependence after IMRT±chemotherapy for oropharyngeal cancer.
    Sanguineti G; Rao N; Gunn B; Ricchetti F; Fiorino C
    Radiother Oncol; 2013 Jun; 107(3):300-4. PubMed ID: 23773408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
    Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
    Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Larynx-sparing techniques using intensity-modulated radiation therapy for oropharyngeal cancer.
    Bar Ad V; Lin H; Hwang WT; Deville C; Dutta PR; Tochner Z; Both S
    Med Dosim; 2012; 37(4):383-6. PubMed ID: 22917963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.
    Strom T; Trotti AM; Kish J; Rao NG; McCaffrey J; Padhya TA; Lin HY; Fulp W; Caudell JJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1242-6. PubMed ID: 24136493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia.
    Fua TF; Corry J; Milner AD; Cramb J; Walsham SF; Peters LJ
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):976-81. PubMed ID: 17234360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
    Sanguineti G; Gunn GB; Parker BC; Endres EJ; Zeng J; Fiorino C
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):52-9. PubMed ID: 20418027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.